Search Clinical Trials
597,783 trials
ID
Status
Phase
Title
Sponsor
NCT07757568
Prospective Evaluation of De-Escalation From antiCD-20 Therapies to Dimethyl Fumarate (Tecfidera) or Diroximel Fumarate (Vumerity)University of Colorado, DenverActive Not Recruiting
NCT07757568Active Not Recruiting
—
Prospective Evaluation of De-Escalation From antiCD-20 Therapies to Dimethyl Fum...University of Colorado, D...
NCT07757672
Salvage Chemotherapy With Sonrotoclax, Cladribine, and Standard-dose Cytarabine, Sequentially Followed by HSCT for R/R AML.Institute of Hematology & Blood Diseases Hospital, ChinaNot Yet RecruitingPhase 1
NCT07757672Not Yet Recruiting
Phase 1
Salvage Chemotherapy With Sonrotoclax, Cladribine, and Standard-dose Cytarabine,...Institute of Hematology &...
NCT07757815
Multimodal Biomarkers and Precision TMS for Postpartum DepressionKiang Wu HospitalNot Yet RecruitingNot Applicable
NCT07757815Not Yet Recruiting
Not Applicable
Multimodal Biomarkers and Precision TMS for Postpartum DepressionKiang Wu Hospital
NCT07758959
Comparison of Purse String Suture vs Transverse Mattress Suture to Maintain Hemostasis in Thinned-out Caesarean Sections ScarsLahore General HospitalActive Not RecruitingNot Applicable
NCT07758959Active Not Recruiting
Not Applicable
Comparison of Purse String Suture vs Transverse Mattress Suture to Maintain Hemo...Lahore General Hospital
NCT07757789
Thrombocytopenia Trajectories in Antiphospholipid Syndrome: A Multicenter Cohort StudyNew Valley UniversityRecruitingNot Applicable
NCT07757789Recruiting
Not Applicable
Thrombocytopenia Trajectories in Antiphospholipid Syndrome: A Multicenter Cohort...New Valley University
NCT07758309
Online Games to Help Canadian and U.S. Adults Identify COVID-19 and Vaccine Misinformation: Three Sequential Randomized StudiesCanadian HeritageCompletedNot Applicable
NCT07758309Completed
Not Applicable
Online Games to Help Canadian and U.S. Adults Identify COVID-19 and Vaccine Misi...Canadian Heritage
NCT07758660
Alzheimer's Disease Research Center (ADRC) PET Component StudyNational Institute on Aging (NIA)Enrolling By InvitationPhase 2
NCT07758660Enrolling By Invitation
Phase 2
Alzheimer's Disease Research Center (ADRC) PET Component StudyNational Institute on Agi...
NCT07757971
2D:4D Ratio in Relation to Anxiety and Stress Among Anesthesiology ResidentsAin Shams UniversityNot Yet Recruiting
NCT07757971Not Yet Recruiting
—
2D:4D Ratio in Relation to Anxiety and Stress Among Anesthesiology ResidentsAin Shams University
NCT07756671
Photodynamic Therapy For OnychomycosisThe University of Texas Health Science Center, HoustonNot Yet RecruitingPhase 1
NCT07756671Not Yet Recruiting
Phase 1
Photodynamic Therapy For OnychomycosisThe University of Texas H...
NCT07758907
Interference and Stability Evaluation of the Intelligent Fingerprinting Drug Screening SystemCenExelEnrolling By InvitationNot Applicable
NCT07758907Enrolling By Invitation
Not Applicable
Interference and Stability Evaluation of the Intelligent Fingerprinting Drug Scr...CenExel
NCT07757191
DURATION-GC: FLOT Plus Durvalumab and TS-1 Plus Durvalumab for Resectable Gastric CancerTaipei Veterans General Hospital, TaiwanNot Yet RecruitingPhase 2
NCT07757191Not Yet Recruiting
Phase 2
DURATION-GC: FLOT Plus Durvalumab and TS-1 Plus Durvalumab for Resectable Gastri...Taipei Veterans General H...
NCT07757607
A Prospective, Multicenter, Single-Arm Study to Support the Clinical Evidence Base for MRace as a Treatment Option for FMR Patients With Complex M-TEER Anatomies (FR)Polares Medical SANot Yet RecruitingNot Applicable
NCT07757607Not Yet Recruiting
Not Applicable
A Prospective, Multicenter, Single-Arm Study to Support the Clinical Evidence Ba...Polares Medical SA
NCT07758790
A Registry Study to Assess SYNTHECELTM Dura RepairDePuy Synthes Products, Inc.Not Yet Recruiting
NCT07758790Not Yet Recruiting
—
A Registry Study to Assess SYNTHECELTM Dura RepairDePuy Synthes Products, I...
NCT07759024
Cesarean Delivery Outcomes in Maternal Critical CareSociété Française d'Anesthésie et de RéanimationNot Yet Recruiting
NCT07759024Not Yet Recruiting
—
Cesarean Delivery Outcomes in Maternal Critical CareSociété Française d'Anest...
NCT07758881
A Prospective Study Evaluating the Safety and Performance of the Eight Medical Hyperthermia System IV 1.0 for HIVEC in NMIBC.Eight Medical International BVNot Yet RecruitingNot Applicable
NCT07758881Not Yet Recruiting
Not Applicable
A Prospective Study Evaluating the Safety and Performance of the Eight Medical H...Eight Medical Internation...
NCT07758504
Comparison of Performing V-Notes Hysterectomy Under Spinal Anesthesia and General AnesthesiaCukurova UniversityNot Yet RecruitingNot Applicable
NCT07758504Not Yet Recruiting
Not Applicable
Comparison of Performing V-Notes Hysterectomy Under Spinal Anesthesia and Genera...Cukurova University
NCT07757074
A Comparative Study of Delayed Endoscopic DTI and Latissimus Dorsi ±Impalnt Reconstruction Post-MastectomyDu ZhengguiNot Yet Recruiting
NCT07757074Not Yet Recruiting
—
A Comparative Study of Delayed Endoscopic DTI and Latissimus Dorsi ±Impalnt Reco...Du Zhenggui
NCT07757165
The Necessity of Surgery in Patients With mGC Achieving Radiological Response After Conversion TherapyFudan UniversityRecruitingPhase 2
NCT07757165Recruiting
Phase 2
The Necessity of Surgery in Patients With mGC Achieving Radiological Response Af...Fudan University
NCT07757984
Regional Nerve Block for Upper Extremity Surgery in Patients With SarcopeniaChang Gung Memorial HospitalNot Yet Recruiting
NCT07757984Not Yet Recruiting
—
Regional Nerve Block for Upper Extremity Surgery in Patients With SarcopeniaChang Gung Memorial Hospi...
NCT07758777
Usability Evaluation of the Intelligent Fingerprinting Drug Screening SystemIntelligent Bio Solutions Inc.CompletedNot Applicable
NCT07758777Completed
Not Applicable
Usability Evaluation of the Intelligent Fingerprinting Drug Screening SystemIntelligent Bio Solutions...
Result Breakdown
Not yet recruiting12 (60%)
Active, not recruiting2 (10%)
Recruiting2 (10%)
Completed2 (10%)
Enrolling by invitation2 (10%)
not_applicable9 (45%)
Not Specified6 (30%)
Phase 23 (15%)
Phase 12 (10%)